NICE

The National Institute for Health and Clinical Excellence (NICE) is the independent organisation responsible for providing national guidance on the promotion of good health and the prevention and treatment of ill health.

NICE produces guidance in three areas of health:

  1. Public health – guidance on the promotion of good health and the prevention of ill health for those working in the NHS, local authorities and the wider public and voluntary sector
  2. Health technologies – guidance on the use of new and existing medicines, treatments and procedures within the NHS
  3. Clinical practice – guidance on the appropriate treatment and care of people with specific diseases and conditions within the NHS.

 

NICE Guidelines for Health Professionals: Bowel disorders

You will see below summaries of latest guidelines and implementations from NICE relating to bowel conditions and problems and links to further information.

NICE Guidelines for Health Professionals: Bladder disorders

You will see below summaries of latest guidelines and implementations and issues under development and review from NICE relating to bladder conditions and problems and links to further information.

*Due to an extended period of ‘high vigilance restriction’ around Mesh repair surgeries, NICE have updated and published additional guidelines on urinary incontinence and pelvic organ prolapse (also listed above) and supplemented this information with patient decision aids to help break down the information for people. Please visit the NICE website for further review updates.

Evidence Summaries

The NICE Evidence Summaries aim to help healthcare professionals make decisions and support the development and updating of local formularies. They do this by collecting the best available evidence for selected medicines that are of significance to the NHS, such as medicines which have been released in the last 6 months or existing medicines that are currently authorised but newly licensed for a new indication.

This aspect of the NICE’s work aims to summarise the best available evidence for certain new medicines, which can also include off-label use of licensed medicines and unlicensed medicines. This evidence, whilst NICE advice, does not include recommendations and is not offered as formal guidance. Each summary is critically reviewed periodically.

For more information please refer to the NICE website overview on evidence summaries.